Ginsenosides Are Novel Naturally-Occurring Aryl Hydrocarbon Receptor Ligands

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hu, Qin ^a   He, Guochun ^b   Zhao, Jing ^b   Soshilov, Anatoly ^b   Denison, Michael S ^b   Zhang, Aiqian ^a   Yin, Huijun ^c   Fraccalvieri, Domenico ^d   Bonati, Laura ^d   Xie, Qunhui ^a   Zhao, Bin ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c XIYUAN HOSPITAL   (China)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; GINSENOSIDE; GINSENOSIDE F 11; GINSENOSIDE PPD; GINSENOSIDE PPT; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RB 3; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; GINSENOSIDE RH 1; GINSENOSIDE RH 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; CYP1A1 GENE; CYTOSOL; DNA BINDING; DRUG STRUCTURE; GENE EXPRESSION; GENETIC ANALYSIS; GINSENG; GUINEA PIG; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DOCKING; MOUSE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANIMALS; CELL LINE, TUMOR; GINSENOSIDES; GUINEA PIGS; HUMANS; MICE; RATS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

CAVIA; PANAX GINSENG; RATTUS;

EID: 84878829776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066258     Document Type: Article

References (53)

1. Schmidt JV, Bradfield CA, (1996) Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55-89.
2. Safe S, (1990) Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol 21: 51-88.
3. Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B, (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124: 1-22.
4. Kazlauskas A, Poellinger L, Pongratz I, (1999) Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J Biol Chem 274: 13519-13524.
5. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH, (1998) Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 18: 978-988.
6. Hankinson O, (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35: 307-340.
7. Soshilov A, Denison MS, (2011) Ligand displaces heat shock protein 90 from overlapping binding sites within the aryl hydrocarbon receptor ligand-binding domain. J of Biol Chem 286: 35275-35282.
8. Denison MS, Seidel SD, Rogers WJ, Ziccardi M, Winter GM, et al. (1998) Natural and synthetic ligands for the Ah receptor. Molecular Biology Approaches to Toxicology (Puga A, Kendall RJ, eds). London: Taylor and Francis, 3-33.
9. Ashida H, Fukuda I, Yamashita T, Kanazawa K, (2000) Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett 476: 213-217.
10. DeGroot D, He G, Fraccalvieri D, Bonati L, Pandini A, et al. (2011) AHR ligands: promiscuity in binding and diversity in response. In: The Ah receptor in biology and toxicology, edited by Pohjanvirta R. 63-79, John Wiley & Sons, Inc. Hoboken, NJ.
11. Denison MS, Nagy SR, (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-334.
12. Hestermann EV, Stegeman JJ, Hahn ME, (2000) Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol Appl Pharmacol 168: 160-172.
13. Huang KC, Williams WM (1999) The pharmacology of Chinese herbs. CRC.
14. Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, et al. (1993) Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. Oncol. J Cancer Res Clin 120: 24-36.
15. Wang Y, Ye X, Ma Z, Liang Q, Lu B, et al. (2008) Induction of cytochrome P4501A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells. European journal of pharmacology 601: 73-78.
16. Delescluse C, Lemaire G, Sousa G, Rahmani R, (2000) Is CYP1A1 induction always related to AHR signaling pathway? Toxicology 153: 73-82.
17. Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR, (2007) Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol 71: 1475-1486.
18. Vecchini F, Lenoir-Viale MC, Cathelineau C, Magdalou J, Bernard BA, et al. (1994) Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem Biophys Res Commun 201: 1205-1212.
19. Garrison PM, Tullis K, Aarts JM, Brouwer A, Giesy JP, et al. (1996) Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam Appl Toxicol 30: 194-203.
20. Han D, Nagy SR, Denison MS, (2004) Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. Biofactors 20(1): 11-22.
21. Denison MS, Rogers JM, Rushing SR, Jones CL, Tetangco SC, et al. (2002) Analysis of the Ah receptor signal transduction pathway, in: Current Protocols in Toxicology (Maines M, Costa LG, Reed DJ, Sassa S and Sipes IG, eds.). pp 4.8.1-4.8.45, John Wiley and Sons, NY.
22. Motto I, Bordogna A, Soshilov AA, Denison MS, Bonati L, (2011) New Aryl Hydrocarbon Receptor Homology Model Targeted to Improve Docking Reliability. J Chem Inf Model 51: 2868-2881.
23. Sali A, Blundell TL, (1993) Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
24. Marti-Renom MA, Stuart A, Fiser A, Sanchez R, Melo F, et al. (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325.
25. Fiser A, Do RK, Sali A, (2000) Modeling of loops in protein structures. Protein Sci 9: 1753-1773.
26. Shen M, Sali A, (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15: 2507-2524.
27. MacroModel, version 9.9, Schrödinger, LLC: New York, NY, 2012.
28. Maestro, version 9.3, Schrödinger, LLC: New York, NY, 2012.
29. Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL, (2001) Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides. J Phys Chem B 105: 6474-6487.
30. Still WC, Tempczyk A, Hawlely RC, Hendrickson TA, (1990) General treatment of solvation for molecular mechanics. J Am Chem Soc 112: 6127-6129.
31. Glide, version 5.8, Schrödinger, LLC: New York, NY, 2012.
32. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, et al. (2006) Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49: 6177-6196.
33. Shigeyuki Uno, Kaori Endo, Yuji Ishida, Chise Tateno, Makoto Makishima, et al. (2009) CYP1A1 and CYP1A2 expression: Comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines. Toxicology and Applied Pharmacology 237: 119-126.
34. Bordogna A, Pandini A, Bonati L, (2011) Predicting the accuracy of protein-ligand docking on homology models. J Comput Chem 32: 81-98.
35. Fraccalvieri D, Soshilov AA, Karchner SI, Franks DG, Pandini A, et al. (2013) Comparative analysis of homology models of the Ah receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor. Biochemistry 52: 714-725.
36. Pandini A, Denison MS, Song Y, Soshilov AA, Bonati L, (2007) Structural and functional characterization of the Aryl hydrocarbon receptor ligand binding domain by homology modeling and mutational analysis. Biochemistry 46: 696-708.
37. Pandini A, Soshilov AA, Song Y, Zhao J, Bonati L, et al. (2009) Detection of the TCDD binding fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis, Biochemistry. 48: 5972-5983.
38. Denison MS, Vella LM, Okey AB, (1986) Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Species difference in molecular properties of the receptors from mouse and rat hepatic cytosols. J Biol Chem 261: 3987-3995.
39. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA, (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci U S A 88: 9543-9547.
40. Ciolino HP, Daschner PJ, Yeh GC, (1998) Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58: 5707-5012.
41. Henry EC, Gasiewicz TA, (2003) Agonist but not antagonist ligands induce conformational change in the mouse aryl hydrocarbon receptor as detected by partial proteolysis. Mol Pharmacol 63: 392-400.
42. Mukai R, Shirai Y, Saito N, Fukuda I, Nishiumi S, et al. (2010) Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction. Arch Biochem Biophys 501: 134-141.
43. Hooper LV, (2011) You AHR what you eat: linking diet and immunity. Cell 147: 489-491.
44. Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, et al. (2011) Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147: 620-629.
45. Puga A, Ma C, Marlowe JL, (2009) The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 77: 713-722.
46. Nagy SR, Sanborn JR, Hammock BD, Denison MS, (2002) Development of a green fluorescent protein-based cell bioassay for the rapid and inexpensive detection and characterization of ah receptor agonists. Toxicol Sci 65: 200-210.
47. Seidel SD, Li V, Winter GM, Rogers WJ, Martinez EI, et al. (2000) Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists. Toxicol Sci 55: 107-115.
48. Sakakibara K, Shibata Y, Higashi T, Sanada S, Shoji J, (1975) Effect of ginseng saponins on cholesterol metabolism. I. The level and the synthesis of serum and liver cholesterol in rats treated with ginsenosides. Chem Pharm Bull (Tokyo) 23: 1009-1016.
49. Joh EH, Lee IA, Jung IH, Kim DH, (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochemical pharmacology 82: 278-286.
50. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, et al. (2002) Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51: 1851-1858.
51. Lee KT, Jung TW, Lee HJ, Kim SG, Shin YS, et al. (2011) The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Archives of pharmacal research 34: 1201-1208.
52. Chen X, (1996) Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clinical and experimental pharmacology and physiology 23: 728-732.
53. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, et al. (1994) Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biological & pharmaceutical bulletin 17: 635-639.